Pfizer's (NYSE:PFE) Solid Earnings Are Supported By Other Strong Factors

NYSE:PFE Earnings and Revenue History November 11th 2025 How Do Unusual Items Influence Profit? To properly understand Pfizer ...

Stock market today: S&P 500, Nasdaq soar, lead Dow higher as Senate vote lifts hopes for end to US shutdown

Markets have turned upbeat amid optimism that the 39-day US shutdown could soon come to an end, after a weekend of dealmaking in Washington. A new bill quickly advanced in a key S ...
Zacks Investment Research on MSN

Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
TipRanks on MSN

Pfizer’s Earnings Shine Amid Analyst Caution

Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer has recently reported solid ...

Pfizer: The Storm Has Passed -- Tailwinds Ahead

Discover why Pfizer Inc. is rated a Strong Buy with 33% upside, robust dividends, and growth prospects ahead. Click for my updated look at PFE stock.

J.P. Morgan Keeps Their Hold Rating on Pfizer (PFE)

J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer today and set a price target of $30.00. The company’s shares closed yesterday at $24.66. Take advantage of TipRanks Premium at 50% ...

Pfizer (PFE) Receives a Hold from TD Cowen

Currently, the analyst consensus on Pfizer is a Hold with an average price target of $28.60, representing a 15.98% upside. In a report released today, J.P. Morgan also maintained a Hold rating on the ...

Pfizer: Market Still Pricing It At Crisis Valuations

Pfizer Inc. is rated a Buy with stable guidance, robust pipeline, strong free cash flows & appealing dividend yield. Learn ...